Page 9 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Axsm Today - Breaking & Trending Today
Endurant Capital Management LP bought a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 11,264 shares of the company’s stock, valued at approximately $869,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] ....
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. […] ....
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating)’s share price was up 4% during mid-day trading on Wednesday . The stock traded as high as $72.47 and last traded at $72.24. Approximately 294,226 shares changed hands during trading, a decline of 67% from the average daily volume of 884,269 shares. The stock had previously closed at […] ....
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – Analysts at Zacks Research cut their Q2 2023 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a research note issued on Monday, May 22nd. Zacks Research analyst K. Shah now expects that the company will post earnings of ($1.32) per share for the quarter, […] ....
Axsome Therapeutics (NASDAQ:AXSM – Get Rating) had its price objective upped by Guggenheim from $90.00 to $100.00 in a research report sent to investors on Tuesday morning, The Fly reports. AXSM has been the topic of a number of other research reports. StockNews.com began coverage on Axsome Therapeutics in a research report on Thursday, March […] ....